# Collagenase Option for Reduction of Dupuytren's Contracture in Japan

> **NCT01588353** · PHASE3 · COMPLETED · sponsor: **Asahi Kasei Therapeutics Corporation** · enrollment: 104 (actual)

## Conditions studied

- Dupuytren's Contracture

## Interventions

- **DRUG:** Collagenase Clostridium Histolyticum

## Key facts

- **NCT ID:** NCT01588353
- **Lead sponsor:** Asahi Kasei Therapeutics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2017-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01588353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01588353, "Collagenase Option for Reduction of Dupuytren's Contracture in Japan". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01588353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*